These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3022035)

  • 1. Alternating non-cross resistant chemotherapy for small cell lung cancer.
    Fukuoka M; Takada M; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Kudoh S; Tamai S
    Jpn J Clin Oncol; 1986 Sep; 16(3):261-70. PubMed ID: 3022035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination versus alternating chemotherapy in small-cell lung cancer.
    Lai SL; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
    Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report.
    Ohnoshi T; Hiraki S; Kawahara S; Yamashita H; Yonei T; Ishii J; Egawa T; Kozuka A; Hiraki Y; Kimura I
    Jpn J Clin Oncol; 1986 Sep; 16(3):271-7. PubMed ID: 3022036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung.
    Warner-Efrati E; Sulkes A; Weshler Z; Peretz T; Ben-Yosef R; Catane R; Biran S
    Isr J Med Sci; 1988; 24(9-10):593-8. PubMed ID: 2849598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.
    Osterlind K; Sörenson S; Hansen HH; Dombernowsky P; Hirsch FR; Hansen M; Rørth M
    Cancer Res; 1983 Dec; 43(12 Pt 1):6085-9. PubMed ID: 6315227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
    Pujol JL; Carestia L; Daurès JP
    Br J Cancer; 2000 Jul; 83(1):8-15. PubMed ID: 10883661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung.
    Krauss S; Lowenbraun S; Bartolucci A; Buchanan R; Birch R
    Cancer Clin Trials; 1981; 4(2):147-53. PubMed ID: 6265109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
    Messeih AA; Schweitzer JM; Lipton A; Harvey HA; Simmonds MA; Stryker JA; Ricci JA; Hoffman SL; Gottleib RJ; Dixon RH
    Cancer Treat Rep; 1987 Jan; 71(1):61-6. PubMed ID: 3024828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
    Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB; Schulman S; Mira JG; Harker G; Vogel S; Coltman CA; Rivkin SE; Budd GT; Grever MR; Crowley JP
    Cancer Treat Rep; 1986 Dec; 70(12):1395-401. PubMed ID: 3024826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating combination chemotherapy regimens in small-cell lung cancer.
    Natale RB; Wittes RE
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):7-13. PubMed ID: 2983436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.